The role of specific drug or drugs can be difficult to evaluate in those patients receiving combinatorial therapy. Please consult current list or lists of antiviral agents elsewhere at all time, as a class effect is possible if not likely

Last update : 05/02/2019
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar hemorrhage
IV - Airway involvement
V - Pleural and/or pericardial involvement
X - Systemic/Distant conditions, syndromes and reactions
XI - Miscellaneous
XV - Pathology
XVI - Imaging
XVII - Infections & related conditions
XIX - Cytological, biochemical features of/in BAL, pleural fluid or FNA